Jimin Tan

Assistant Professor

NYU School of Medicine
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Year:

2025

Analyzing whole tissue architecture remains challenging due to the inherent complexity of multicellular organization, variable morphology, and the limitations of conventional segmentation-based image analysis. Traditional approaches often rely on partial sampling or nuclear/cytoplasmic boundaries, which risk introducing bias and fail to capture the contextual interplay of diverse tissue compartments. To overcome these barriers, we developed a segmentation free framework for analyzing multispectral whole slide images (WSIs). By tiling WSIs into fixed sized regions and extracting quantitative tile features, we applied unsupervised machine learning to systematically reveal patterns of tissue organization at scale. This approach preserved spatial context without the need for cell-level delineation, recapitulating expected compartments such as epidermis, adipose, and scab, while also revealing subtle but coherent substructures within stromal and granulation regions. Applied to murine wound healing, the method distinguished wild type from diabetic repair dynamics without prior labels, uncovering both gross and nuanced differences in tissue composition. Together, this work establishes a robust, unbiased strategy for whole-tissue analysis that circumvents the limitations of segmentation, leverages unsupervised learning for discovery, and advances the study of tissue repair and regenerative pathology.

Year:

2025

The identity of a cell is governed by regulatory proteins binding to the genome to control gene expression. Mapping these genome-wide binding events across thousands of proteins and cell types is essential for understanding development and disease at scale, yet has remained a major experimental and computational barrier. Here we present Chromnitron, a multimodal foundation model that learns the rules of protein-DNA binding from protein sequence, DNA sequence, and context-specific chromatin states. Unlike prior single-task and multi-task learning approaches, Chromnitron implements a multimodal learning framework that accurately predicts the binding landscape for proteins and cell types not seen during training. Using Chromnitron, we discovered and experimentally validated new protein regulators of T cell exhaustion. Chromnitron also uncovered previously uncharacterized dynamic shifts in the binding landscape of regulatory proteins during neurogenesis. This marks a critical step toward a predictive model of interpretable gene regulatory programs across cell types, enabling rapid discovery of regulatory circuits and identification of new therapeutic targets.

Year:

2025

Brain tumors affect about 1 million people in the U.S., with aggressive types like glioblastoma having very low survival rates due to complex tumor biology and the protective blood-brain barrier. Current treatments are limited in effectiveness, and our understanding of brain tumor biology remains incomplete. High dimensional multiplexed imaging has enabled us to better understand the tumor microenvironment (TME); however, analyses typically rely on cell segmentation, which is error-prone, may discard useful context outside the cell boundary, and neglects complex tissue-wide features. To address this limitation, we developed a segmentation-free, self-supervised representation learning framework that enables us to train directly on multiplexed images using masked image modeling. We used this approach to analyze 389 imaging mass cytometry images from 185 brain tumor patients. To study tissue-wide features, we first trained our model on 64×64 micron tiles capturing neighborhoods of 10-20 cells, which we termed local tumor microenvironments (LTMEs). To further characterize these LTMEs, we trained our model on 16×16 micron tiles centered on individual cells in our dataset, so that each tile captures a single cell and its surrounding area, which we termed single-cell microenvironments (SCMEs). This multi-scale, self-supervised approach enables a detailed analysis of the heterogeneity within the brain TME, examining single cells in their spatial context. In addition to validating known findings, we identified a novel LTME in GBM patients, composed primarily of tumor cells and a few B and T cells, which strongly correlated with increased survival. By analyzing these B cells with our SCME model, we found they were distinct from other GBM B cells, and higher concentrations of these B cells were linked to improved survival. In conclusion, our study introduces a multi-scale, segmentation-free, self-supervised machine learning model that provides unprecedented insights into brain TMEs, enabling discovery of previously unrecognized cell interactions and spatial features that are predictive of patient survival.

Year:

2025

The interaction between tumors and their microenvironment is complex and heterogeneous. Recent developments in high-dimensional multiplexed imaging have revealed the spatial organization of tumor tissues at the molecular level. However, the discovery and thorough characterization of the tumor microenvironment (TME) remains challenging due to the scale and complexity of the images. Here, we propose a self-supervised representation learning framework, CANVAS, that enables discovery of novel types of TMEs. CANVAS is a vision transformer that directly takes high-dimensional multiplexed images and is trained using self-supervised masked image modeling. In contrast to traditional spatial analysis approaches which rely on cell segmentations, CANVAS is segmentation-free, utilizes pixel-level information, and retains local morphology and biomarker distribution information. This approach allows the model to distinguish subtle morphological differences, leading to precise separation and characterization of distinct TME signatures. We applied CANVAS to a lung tumor dataset and identified and validated a monocytic signature that is associated with poor prognosis.

Year:

2024

Year:

2023

Collaborators (9)

Aristotelis Tsirigos

Associate Professor (Research) of Pathology

NYU School of Medicine

UNITED STATES
View details

Matija Snuderl

Assistant Professor (Clinical) of Pathology

NYU School of Medicine

UNITED STATES
View details

Francesco Boccalatte

Principal Investigator

Candiolo Cancer Institute

ITALY
View details

Valeria Mezzano

Research Assistant Professor

NYU School of Medicine

UNITED STATES
View details

Xi Fu

Columbia University Irving Medical Center

UNITED STATES
View details

Piul Rabbani

Assistant Professor

NYU School of Medicine

UNITED STATES
View details

Jef Boeke

Professor of Biochemistry and Molecular Pharmacology (Academic)

NYU School of Medicine

UNITED STATES
View details

Bo Xia

Associate Member

Broad Institute

UNITED STATES
View details

David Fenyo

Professor

New York University

UNITED STATES
View details